DUBLIN--(BUSINESS WIRE)--The "Global Companion Diagnostics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The companion diagnostics market will register a CAGR of almost 25% by 2023.
The growing importance for promotional activities to drive market growth
The companion diagnostics are not as frequently marketed like other test kits and devices that are available in the market due to its specificity, wherein it can be used only for a drug. Therefore, more emphasis must be provided toward improving distribution network and increasing the product availability to end-users. Online media and search engines are the primary sources for advertising, owing to the low return on investment and limited visibility of other media.
Rising use of personalized medicine
Personalized medicine is a multi-faceted method to patient care that not only improves capacity to diagnose and treat diseases but offers the potential to distinguish diseases at an earlier stage, which makes it easier for practitioners to treat effectively. With its specificity in treating particular disease based on an individual's genetic characteristics, personalized medicine is gaining popularity.
Lack of manpower
Companion diagnostic tests are highly technical, and care must be taken at each step to facilitate a successful execution of these tests, to generate reproducible results. A major challenge in these scientific fields is the lack of technically skilled and trained staff.
Key Players
- Abbott
- Agilent Technologies
- F. Hoffmann-La Roche
- QIAGEN
- Thermo Fisher Scientific
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY END-USER
- Comparison by end-user
- Life science - Market size and forecast 2018-2023
- Health centers - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- Agilent Technologies
- F. Hoffmann-La Roche
- QIAGEN
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/mv96s8/global_companion?w=4
